Peter Bluford - Net Worth and Insider Trading
Peter Bluford Net Worth
The estimated net worth of Peter Bluford is at least $122,959 dollars as of 2024-09-20. Peter Bluford is the VP, Corporate Development of Sangamo Therapeutics Inc and owns about 136,591 shares of Sangamo Therapeutics Inc (SGMO) stock worth over $122,959. Details can be seen in Peter Bluford's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Peter Bluford has not made any transactions after 2004-09-27 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Peter Bluford
Peter Bluford Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Peter Bluford owns 1 companies in total, including Sangamo Therapeutics Inc (SGMO) .
Click here to see the complete history of Peter Bluford’s form 4 insider trades.
Insider Ownership Summary of Peter Bluford
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SGMO | Sangamo Therapeutics Inc | 2004-09-27 | V.P. & Corporate Development |
Peter Bluford Latest Holdings Summary
Peter Bluford currently owns a total of 1 stock. Peter Bluford owns 136,591 shares of Sangamo Therapeutics Inc (SGMO) as of September 27, 2004, with a value of $122,959.
Latest Holdings of Peter Bluford
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SGMO | Sangamo Therapeutics Inc | 2004-09-27 | 136,591 | 0.90 | 122,959 |
Holding Weightings of Peter Bluford
Peter Bluford Form 4 Trading Tracker
According to the SEC Form 4 filings, Peter Bluford has made a total of 0 transactions in Sangamo Therapeutics Inc (SGMO) over the past 5 years. The most-recent trade in Sangamo Therapeutics Inc is the sale of 500 shares on September 27, 2004, which brought Peter Bluford around $2,500.
Insider Trading History of Peter Bluford
- 1
Peter Bluford Trading Performance
Peter Bluford Ownership Network
Peter Bluford Owned Company Details
What does Sangamo Therapeutics Inc do?
Who are the key executives at Sangamo Therapeutics Inc?
Peter Bluford is the V.P. & Corporate Development of Sangamo Therapeutics Inc. Other key executives at Sangamo Therapeutics Inc include 10 percent owner Biogen Inc. , SVP-Chief Development Officer Nathalie Dubois-stringfellow , and 10 percent owner Biogen Ma Inc. .
Sangamo Therapeutics Inc (SGMO) Insider Trades Summary
Over the past 18 months, Peter Bluford made no insider transaction in Sangamo Therapeutics Inc (SGMO). Other recent insider transactions involving Sangamo Therapeutics Inc (SGMO) include a net sale of 6,000,000 shares made by Biogen Inc. ,
In summary, during the past 3 months, insiders sold 0 shares of Sangamo Therapeutics Inc (SGMO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 6,000,000 shares of Sangamo Therapeutics Inc (SGMO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 6,000,000 shares.
Sangamo Therapeutics Inc (SGMO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Sangamo Therapeutics Inc Insider Transactions
Peter Bluford Mailing Address
Above is the net worth, insider trading, and ownership report for Peter Bluford. You might contact Peter Bluford via mailing address: C/o Sangamo Biosciences In Ste.a-100, Point Richmond Tech Center 501 Cana Blvd, Richmond Ca 94804.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
